Galveston National Laboratory GNL Timeline 2018GNL Celebrates 10th Anniversary (November 2018) 2017Biodefense Strategy for U.S. Becomes Major Priority; GNL Has Seat at the Policy Table. 2016 UT Chancellor William McRaven Makes National Security, Including Biosecurity, a UT System Priority 2015GNL’s Expertise in Vector Borne Diseases, including Chikungunya and Zika Play Major Role in International Research 2014West African Ebola Outbreak Puts GNL and Ebola Research at Forefront of Infectious Disease Attention 2013Vaccine and Other Medical Countermeasures Are Major Focus at GNL 2010GNL Begins Increasing Capacity with BSL2, BSL3 and BSL4 Labs all Increasing Research 2008Galveston National Laboratory Opened 2006UC7 Galveston National Laboratory Operations 2005Galveston National Laboratory ground-breaking 2004Robert E. Shope BSL-4 Laboratory / John Sealy Pavilion opens Institute for Human Infections & Immunity 2003Western Regional Center of Excellence (RCE) UC6 Galveston National Laboratory (NBL) awards NHLBI RSV Proteomics Center 2002NIAID Hepatitis C Antiviral Contract Shope BSL-4 Laboratory ground-breaking Anthrax attacks 2001UTMB Center for Biodefense UT System approves BSL-4 lab construction 2000Sealy Center for Vaccine Development 1997DARPA Biodefense Grant WHO Collaborating Center for Arbovirus and HF Virus Research NIAID Cooperative Hepatitis C Research Center 1995WHO Collaborating Center for Tropical Diseases World Reference Center for Arboviruses Medical Mycology Reference Center established 1994Center for Tropical Diseases